Learning outcomes
By the end of this lesson you should be able to: define disseminated intravascular coagulation and explain how a single process produces both thrombosis and bleeding; list its major acute and chronic causes; interpret the laboratory profile of DIC and explain each abnormality; distinguish DIC from other thrombocytopenia-and-bleeding states; and describe the principles of its management and their rationale.
Prerequisites
Lesson 5 (thrombosis) and lesson 6 (oedema and shock) from this course, plus the coagulation cascade from physiology. DIC is a derangement of the haemostatic system itself, so Virchow's triad is not the framework here — it is what happens when the whole clotting system is switched on at once.
The big idea
DIC is never a disease in its own right; it is a complication of something else — usually a catastrophe of obstetric, malignant or septic origin. The apparent paradox is the whole lesson: because the coagulation system is switched on everywhere, fibrin is deposited in every small vessel, which uses up the platelets and clotting factors; the body's fibrinolytic system then breaks the fibrin down, generating fragments that themselves prevent normal clotting. The patient bleeds because the system is exhausted by the clotting it has already done, and the organs fail because the microcirculation of every organ is plugged with fibrin.
Consequences on two fronts
| Consequence | Mechanism | Clinical manifestation |
|---|---|---|
| Thrombotic | Microvascular occlusion by fibrin thrombi, platelet aggregates and red cells forced through the narrowed vessels | Ischaemic injury to skin (petechiae, purpura fulminans and acral necrosis), kidney (acute cortical necrosis), brain, adrenal glands and digits |
| Haemorrhagic | Consumption of platelets and factors II, V and VIII, plus fibrin degradation products that inhibit fibrin polymerisation | Oozing from venepuncture sites and lines, epistaxis, haematuria, gastrointestinal haemorrhage, purpura |
The classic description of the acute form is the bleeding one: the patient who bleeds from every recent puncture, whose surgical sites weep and whose urine and stool contain fresh blood. In the chronic form the balance is different — the bleeding is mild or absent, and the dominant picture is thrombosis: red clots forming in a digital cyanosis, or recurrent venous thromboembolism in a patient with disseminated malignancy.
Causes
| Category | Examples | Mechanism of activation |
|---|---|---|
| Obstetric | Abruptio placentae, amniotic fluid embolism, retained dead foetus, septic abortion | Tissue factor released from the placenta and decidua enters the maternal circulation |
| Infections | Sepsis from Neisseria meningitidis and other Gram-negative rods; severe sepsis from any organism; viral haemorrhagic fevers | Endotoxin and cytokines trigger tissue factor expression on monocytes and endothelium |
| Malignancy | Acute promyelocytic leukaemia (the classic leukaemic form), metastatic adenocarcinoma | Tumour tissue factor and procoagulant-rich malignant cells (the granules of promyelocytes) |
| Trauma and burns | Massive soft-tissue trauma, crush injury, burns, extensive surgery | Tissue factor released from injured tissue and haemorrhagic shock |
| Vascular and haemolytic | Giant haemangioma (Kasabach-Merritt), aortic aneurysm, haemolytic transfusion reaction, snake bite | Procoagulant exposure or endothelial injury within an abnormal vessel |
| Other | Acute pancreatitis, fulminant liver failure, heat stroke, transplantation | Circulating enzymes, activated cytokines or direct endothelial damage |
NoteAcute promyelocytic leukaemia deserves its own memory: the malignant promyelocyte granules are intensely procoagulant, and its patients are classically found to be bleeding with a DIC profile at presentation. Treating the leukaemia with all-trans retinoic acid corrects the DIC along with the disease.
Worked example: the laboratory profile
A woman in labour with abruptio placentae begins to bleed from her uterine incision and her venepuncture sites. The samples taken before any transfusion show a platelet count of 35 × 10⁹/L, a prothrombin time twice the control, the activated partial thromboplastin time prolonged, a low fibrinogen, and a very high D-dimer. The blood film shows fragmented red cells.
| Investigation | Expected in DIC | Why |
|---|---|---|
| Platelet count | Low (thrombocytopenia) | Consumed in the widespread platelet aggregation |
| Prothrombin time | Prolonged | Consumption of factors I, II, V and VIII |
| Activated partial thromboplastin time | Prolonged | The same consumption of intrinsic-pathway factors |
| Fibrinogen | Low | Consumed by the fibrin generation; a normal fibrinogen does not exclude DIC because it is an acute-phase reactant and often starts high |
| D-dimer and fibrin degradation products | High | Fibrinolysis of the microvascular fibrin deposits — the most sensitive clue |
| The blood film | Schistocytes and helmet cells | Red cells sheared by fibrin strands in the microcirculation — microangiopathic haemolysis |
Read the pattern as a story: the D-dimer was generated by clot, so something has clotted; the platelet count, PT and fibrinogen have fallen, so the clotting has consumed the machinery; the schistocytes are the signature of the fibrin mesh inside the microcirculation. The consumption of a factor profile is the picture of a haemostatic system running out of its own parts.
Distinguishing DIC from its mimics
| Condition | Platelets | Coagulation times | Fibrinogen | Distinguishing feature |
|---|---|---|---|---|
| DIC | Low | Both prolonged | Low | Consumption with high D-dimer; fibrinolytic debris present |
| Thrombotic thrombocytopaenic purpura | Low | Normal (PT/APTT) | Normal | Microangiopathic haemolysis with neurological change, fever and renal failure, but clotting times are normal |
| Heparin-induced thrombocytopenia | Low | PT normal; APTT may be prolonged by heparin | Normal | Exposure to heparin 5-10 days before, and thrombosis rather than bleeding |
| Severe liver failure | Low | Prolonged | Low | A clinical history of liver disease, and D-dimer is not raised unless DIC is superimposed |
The distinction matters for acute medicine, because heparin is the wrong treatment for TTP but is central to the thrombotic forms of DIC. The commonest error in examinations is the platelet count alone; read the coagulation times and the D-dimer together.
Management
There is no single drug for DIC; it is managed by treating the cause and replacing what is missing while giving the system a chance to correct itself. Platelets, fresh frozen plasma and cryoprecipitate are given to a bleeding patient based on the laboratory results and blood loss. In the rare thrombosis-dominated forms — chronic DIC of malignancy, purpura fulminans, or acral ischaemia — low-dose heparin is given deliberately, because the treatment is to halt the consumption. Supportive care of the organ failure follows the shock and acute kidney injury lessons of the course, and the outcome depends almost entirely on the underlying cause.
Common mistakes
Watch outSaying a low fibrinogen excludes DIC, or that a normal platelet count rules it out. Early DIC can exist with a normal fibrinogen (fibrinogen is an acute-phase protein and often rises before it falls) and the platelet count falls before the coagulation times change.
Watch outTreating a bleeding DIC patient with heparin as a first reflex. In the common haemorrhagic forms, replacement and treating the cause are the answer; heparin is reserved for the thrombotic forms of the disease.
Watch outExplaining the purpura as a platelet problem from thrombocytopenia alone. The purpura fulminans of DIC is a thrombotic lesion: fibrin thrombi occlude the skin vessels, and the skin necrosis is a microvascular infarction — bleeding into the skin comes from consumption of factors, not from an immune platelet disorder.
Check your understanding
A patient has DIC. Why does the patient bleed, and why does the patient clot at the same time?
Which single laboratory test best points to ongoing microvascular fibrin generation in a suspected DIC?
Multiple choice
Which best describes the primary defect in disseminated intravascular coagulation?
Which set of results is characteristic of acute DIC?
A patient with acute promyelocytic leukaemia is bleeding from venepuncture sites with a low fibrinogen and schistocytes. Which process explains this?
Which is the correct first-line approach in the bleeding patient with acute DIC?
A patient has thrombocytopenia, neurological changes, fever, normal coagulation times and a normal fibrinogen. Which is the most likely diagnosis?
Summary and next
Disseminated intravascular coagulation is one process with two faces: thrombin generated in the microcirculation plugs the smallest vessels and consumes the clotting system, so the patient bleeds from the very factors the clotting has exhausted. It is diagnosed in the laboratory as low platelets, prolonged coagulation times, low fibrinogen and a high D-dimer, and treated by treating its cause and replacing what is missing. The specialty that follows will take the same haemostatic system and show it behaving in a far more controlled way: the haemodynamic disorders you have just finished are now behind you, and the neoplasia module begins.
Next: neoplasia — the disease of the cell's own control of its division, from the benign adenoma to the metastasising carcinoma.